Astrazeneca earnings were $7.8B for the trailing 12 months ending Mar 31, 2025, with 22.5% growth year over year. The latest AZN earnings report on Mar 31, 2025 announced Q1 2025 earnings of $2.9B, up 94.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AZN reported annual earnings of $7.0B, with 18.1% growth. The next AZN earnings date is Jul 29, 2025.
AZN past earnings growth
How has AZN's earnings growth performed historically?
On AZN's earnings call on Invalid Date, Astrazeneca (NASDAQ: AZN) reported Q1 2025 earnings per share (EPS) of $0.94, up 33.33% year over year. Total AZN earnings for the quarter were $2.92 billion. In the same quarter last year, Astrazeneca's earnings per share (EPS) was $0.71.
The next AZN earnings date is Invalid Date. Add AZN to your watchlist to be reminded of Astrazeneca's next earnings date.
Is Astrazeneca profitable or losing money?
As of the last Astrazeneca earnings report, Astrazeneca is currently profitable. Astrazeneca's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $7.77 billion, a 22.76% increase year over year.
What was AZN's earnings growth in the past year?
As of Astrazeneca's earnings date in Invalid Date, Astrazeneca's earnings has grown 22.49% year over year. This is 92 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 114.49%. AZN earnings in the past year totalled $7.77 billion.
What are Astrazeneca's earnings expectations?
The current EPS estimate for Astrazeneca's earnings report in Invalid Date is $1.09.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.